Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rebecca L Aft, M.D, Ph.D.
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis, Missouri, United States
Andrew Davis, M.D.Antonella Rastelli, M.D.Ashley Frith, M.D.Caron Rigden, M.D.Cynthia X Ma, M.D., Ph.D.Fei Wan, Ph.D.Foluso Ademuyiwa, M.D.Julie Margenthaler, M.D.Katherine N Weilbaecher, M.D.Lindsay Peterson, M.D.Peter Oppelt, M.D.Rama Suresh, M.D.Rebecca L Aft, M.D., Ph.D.Ron Bose, M.D., Ph.D.William Gillanders, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jan 2017
- Primary completion
- 31 Jan 2027
- Completion
- 31 Jul 2032
- Last update posted
- 28 Jul 2025
- Registered enrollment
- 50
- Registry id
- NCT02476786
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.